Aptimmune Named Number Three of Seven Ag Tech Start-ups to Watch in 2018
Categories : Features, Recognition & Awards
Posted on: January 30, 2018
EnterpriseWorks startup, Aptimmune Biologics, was recently recognized as one of seven Ag Tech start-ups to watch in 2018 by Agriculture.com.
Aptimmune focuses on developing revolutionary swine vaccines and the prevention of the diseases, porcine reprodutive, respiratory syndrome virus ({PRRSV), and influenza.
In November, Aptimmune launched the industry’s first inactivated mucosal influenza A virus vaccine in swine.
Recently, the company raised $6 Million Series B Funding from various investors and has moved its headquarters to St. Louis.
To see a complete list of Ag Tech startups to watch click here.
Visit Aptimmune’s website here.